The effects of acute and preventive migraine therapies in a mouse model of chronic migraine

Alycia F. Tipton, Igal Tarash, Brenna McGuire, Andrew Charles, Amynah A. Pradhan

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Background The development of novel migraine therapies has been slow, in part because of the small number of clinically relevant animal models. We have recently developed a new mouse model of chronic migraine using chronic intermittent nitroglycerin, a known human migraine trigger. The objective of this study was to validate this model by testing known and potential migraine-preventive treatments. Methods Migraine therapies were administered to male and female mice for 11 days. On day 3, mice were tested with nitroglycerin every second day for nine days. Basal and nitroglycerin-evoked mechanical hypersensitivity was evaluated using von Frey filaments. Results Chronic intermittent nitroglycerin produced acute hyperalgesia with each administration, and progressive and sustained basal hypersensitivity. The established preventive migraine therapy propranolol effectively blocked the development of acute and chronic nitroglycerin-induced hyperalgesia, while valproate had no effect. Potential migraine-preventive therapies were also tested: Amiloride inhibited nitroglycerin-induced acute and chronic hyperalgesia; while memantine was ineffective. We also tested the acute migraine therapy sumatriptan, which did not alter nitroglycerin-induced hyperalgesia, but instead resulted in acute and chronic hyperalgesia similar to that observed following nitroglycerin administration. Conclusions This study establishes the chronic nitroglycerin model as an additional screening tool to test novel migraine-preventive therapies.

Original languageEnglish
Pages (from-to)1048-1056
Number of pages9
Issue number11
StatePublished - Oct 1 2016


  • Allodynia
  • pain
  • prophylactic
  • triptan


Dive into the research topics of 'The effects of acute and preventive migraine therapies in a mouse model of chronic migraine'. Together they form a unique fingerprint.

Cite this